An observational study in Gynecologic Cancer Survivors, sponsored by Abramson Cancer Center at Penn Medicine. Enrolling by invitation at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by Abramson Cancer Center at Penn Medicine · Observational
The goal of this observational study is to learn about the communication systems of gynecologic cancer survivors by conducting focus groups and disseminating a survey.
Gynecologic cancer survivors at Penn Medicine who have consented to being contacted for participation in research will be asked to join the study.
First, a mixed-methods study of gynecologic cancer survivors will be conducted to assess perceptions, barriers, and facilitators to discussing gynecologic cancers through the family and community and create a toolkit for communication.
Separately, a network-map will be created to integrate social-community-advocacy-provider map to disseminate information and facilitate community-based participatory research in gynecologic cancers, by leveraging extensive collaborative teams locally and nationally.
Abramson Cancer Center at Penn Medicine is the lead sponsor of 460 studies on the registry; 87 are open to participants now.
Of its 33 completed or terminated interventional studies of FDA-regulated products, 14 (42%) have results posted.
Counted across the registry records on this site, refreshed daily.
Gynecologic cancer survivors at Penn Medicine who have consented to being contacted for participation in research
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients who have been diagnosed with ovarian cancer and have received at least 1 prior line of therapy.
Patients who have been diagnosed with endometrial cancer and have received at least 1 prior line of therapy.
Patients who have been diagnosed with cervical cancer and have received at least 1 prior line of therapy.
Themes Identified from Focus Groups and Surveys
Thematic analysis of transcripts from semi-structured interviews to identify primary thematic categories regarding barriers and facilitators to discussing gynecologic cancer. Count/listing of identified primary qualitative themes will be performed.
Time frame: From enrollment to June 2027.
Plan to share: Yes — Only IPD used in the results publication
No publications or documents are linked to this record.
Started Jun 2026 (actual). Primary completion is estimated for Jun 2027, 12 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Abramson Cancer Center at Penn Medicine →